 Connection
Jean Kutner to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Jean Kutner has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.015 |
|
|
|
-
Reed SM, Austin E, Colborn K, Schilling LM, Kutner JS. Modeling of an alternative reimbursement method for palliative care. Am J Manag Care. 2022 06 01; 28(6):e221-e227.
Score: 0.551
-
Kutner JS, Abernethy AP. Coding Error Resulting in Change in Secondary Outcome Scores in Trial of Safety and Benefit of Discontinuing Statin Therapy Among Terminally Ill Patients. JAMA Intern Med. 2019 01 01; 179(1):126.
Score: 0.435
-
Kutner JS, Ritchie CS, Abernethy AP. Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness-Reply. JAMA Intern Med. 2015 Oct; 175(10):1725-6.
Score: 0.347
-
Kutner JS, Blatchford PJ, Taylor DH, Ritchie CS, Bull JH, Fairclough DL, Hanson LC, LeBlanc TW, Samsa GP, Wolf S, Aziz NM, Currow DC, Ferrell B, Wagner-Johnston N, Zafar SY, Cleary JF, Dev S, Goode PS, Kamal AH, Kassner C, Kvale EA, McCallum JG, Ogunseitan AB, Pantilat SZ, Portenoy RK, Prince-Paul M, Sloan JA, Swetz KM, Von Gunten CF, Abernethy AP. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med. 2015 May; 175(5):691-700.
Score: 0.337
-
Ritchie CS, Kutner JS, Blatchford PJ, Abernethy AP. Response to Davis and Behm (doi: 10.1089/jpm.2017.0608): Discontinuation of Statins. J Palliat Med. 2018 03; 21(3):283.
Score: 0.103
-
Tjia J, Kutner JS, Ritchie CS, Blatchford PJ, Bennett Kendrick RE, Prince-Paul M, Somers TJ, McPherson ML, Sloan JA, Abernethy AP, Furuno JP. Perceptions of Statin Discontinuation among Patients with Life-Limiting Illness. J Palliat Med. 2017 10; 20(10):1098-1103.
Score: 0.097
-
LeBlanc TW, Kutner JS, Ritchie CS, Abernethy AP. Discontinuation of statins in routine care settings. Ann Intern Med. 2013 Jul 02; 159(1):74-5.
Score: 0.074
-
Akgün KM, Krishnan S, Feder SL, Tate J, Kutner JS, Crothers K. Polypharmacy Increases Risk of Dyspnea Among Adults With Serious, Life-Limiting Diseases. Am J Hosp Palliat Care. 2020 Apr; 37(4):278-285.
Score: 0.029
-
McNeil MJ, Kamal AH, Kutner JS, Ritchie CS, Abernethy AP. The Burden of Polypharmacy in Patients Near the End of Life. J Pain Symptom Manage. 2016 Feb; 51(2):178-83.e2.
Score: 0.022
-
Hanson LC, Bull J, Wessell K, Massie L, Bennett RE, Kutner JS, Aziz NM, Abernethy A. Strategies to support recruitment of patients with life-limiting illness for research: the Palliative Care Research Cooperative Group. J Pain Symptom Manage. 2014 Dec; 48(6):1021-30.
Score: 0.020
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|